| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | High mobility group protein B1|High mobility group protein 1|HMG-1|HMGB1|HMG1 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human HMGB1 (High mobility group protein B1) is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of HMGB1 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of HMGB1 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
HMGB1 (High mobility group protein B1) may also be referenced as High mobility group protein B1, High mobility group protein 1, and HMG-1 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how HMGB1 relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.
- Interpreting shifts in HMGB1 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
HMGB1 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Nano-inducer of ferroptosis for targeted chemotherapy of human triple negative breast carcinoma
IF: 7.9 Journal: Biomaterials Advances Author: Radiation Biology & Health Sciences Division, Bhabha Atomic Research Centre, Mumbai 400085, India Cited Date: 2024-04-26
Ag/Au Bimetallic Nanoparticles Trigger Different Cell Death Pathways and Affect Damage Associated Molecular Pattern Release in Human Cell Lines
IF: 6.639 Journal: Cancers Cited Date: 2022-03-24
Serum High-Mobility Group Box 1 and Heme Oxygenase-1 as Biomarkers in COVID-19 Patients at Hospital Admission
IF: 5.6 Journal: International Journal of Molecular Sciences Cited Date: 2023-09-01
Evidence showing lipotoxicity worsens outcomes in covid-19 patients and insights about the underlying mechanisms
IF: 5.458 Journal: iScience Cited Date: 2022-06-02
Cucurbitacin B from Cucurbitaceae Plants: Treating Pancreatic Cancer via Inducing Mitophagy, Inhibiting Glycolysis, and Enhancing Immune Function
IF: 5 Journal: Nutrients Author: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China Cited Date: 2025-09-05
The correlation between the severity of cerebral microbleeds and serum HMGB1 levels and cognitive impairment in patients with cerebral small vessel disease
IF: 4.8 Journal: Frontiers in Aging Neuroscience Author: Henan Joint International Research Laboratory of Neurorestoratology for Senile Dementia, Henan Key Laboratory of Neurorestoratology, Neurology, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China Cited Date: 2023-07-14
Central nervous system and systemic inflammatory networks associated with acute neurological outcomes in COVID-19
IF: 3.9 Journal: Scientific Reports Author: Instituto Nacional de Infectologia Evandro Chagas, Funda??o Oswaldo Cruz, Rio de Janeiro, Brazil. Cited Date: 2025-11-28
sTREM-1, HMGB1, CRP, PCT, sCD14-ST, IL-6, IL-10, sHLA-G, and Vitamin D in Relation to Clinical Scores and Survival in SIRS/Sepsis
IF: 3.9 Journal: Biomedicines Author: Institute of Immunology, Faculty of Medicine, Comenius University, 813 72 Bratislava, Slovakia Cited Date: 2025-10-17
Plecstatin-1 induces an immunogenic cell death signature in colorectal tumour spheroids
IF: 3.796 Journal: Metallomics Cited Date: 2021-01-22
High Mobility Group Box 1 Protein as a Biomarker in Adult Attention Deficit Hyperactivity Disorder
IF: 3.5 Journal: Alpha Psychiatry Author: Department of Psychiatry, Samsun Training and Research Hospital, 55200 Samsun, Turkey Cited Date: 2025-10-24
Azilsartan Suppressed LPS-Induced Inflammation in U937 Macrophages through Suppressing Oxidative Stress and Inhibiting the TLR2/MyD88 Signal Pathway
IF: 2.87 Journal: ACS Omega Cited Date: 2021-02-06